(Q80166757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

At which stage of chronic kidney disease should dyslipidemia be treated? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

chronic renal insufficiency

1 reference

Vera Krane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Christoph Wanner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Nephrology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

176-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0129

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932418%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference